spacer
home > pmps > spring 2019 > a toxic conversation
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

A Toxic Conversation

A cleanroom is one of the biggest single investments any business is likely to make. There are many great reasons why companies literally cannot afford to get it wrong, so it makes sense to ensure it is kept operational for as long as possible. The fact of the matter is that overspecifying on sterilisation could well be increasing the lifetime cost of cleanrooms through the wholly avoidable degradation of furniture and equipment.

All fixtures and fittings in cleanrooms must facilitate Good Manufacturing Practice, meaning that materials from which they are constructed need to be chemically inert. It should also be tough enough to withstand the regular sterilisation, which is why austenitic stainless steel has always been such a common feature in cleanroom design. Furniture and other equipment built from this material will maintain its structural integrity for decades, not years. However, this is only the case when it is looked after properly, which means matching it to the chosen sterilisation option and also ensuring it is not at risk from detergents and disinfectants.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Sue Springett is Commercial Manager at Teknomek, which produces hygienic furniture and equipment. Having previously held similar positions in manufacturing and service industries, she has helped Teknomek introduce a series of new products specifically for cleanroom users.
spacer
Sue Springett
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Northway Biotechpharma Celebrates 15 Years of Growth and Success

Vilnius, Lithuania, July 16, 2019 ─ Northway Biotechpharma, a leading biopharmaceutical contract development and manufacturing organization (CDMO), celebrates its 15th anniversary today. As a midsized CDMO, Northway Biotechpharma is able to provide flexibility and responsiveness backed by a strong foundation in science and technology. The company focuses on understanding its customers and meeting their specific needs without binding them to one single approach. It is able to react rapidly to unexpected project changes, adjusting timelines, capacities and other activities to meet its customers’ evolving needs. On average, Northway Biotechpharma has 25–30 development projects underway each year, ranging from gene cloning to final drug product manufacturing.
More info >>

White Papers

PhlexEview: Transforming Costly Paper Processes into Value Driven Compliance

Phlexglobal Ltd

Looking at some of the challenges of traditional paper-based Trial Master Files (TMFs), and how they can be overcome with Phlexglobal's best in breed electronic TMF system, PhlexEview.
More info >>

 
Industry Events

CPhI & P-MEC India

26-28 November 2019, India Expo Centre, Greater Noida, Delhi NCR, India

As the pharma industry looks increasingly towards India for high quality, low cost pharma solutions, CPhI & P-MEC India is the ideal event for companies wanting to pick up on the latest trends and innovations the market has to offer. At CPhI & P-MEC India, you will meet the movers and shakers from India's pharma machinery, technology and ingredients industries, giving you a competitive advantage that will help grow your business.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement